View Older Stories

Jul 16, 2026 12:54PM Maxim Group Downgrades AtaiBeckley Inc (ATAI) to Hold

Jul 16, 2026 11:53AM Cantor Fitzgerald Downgrades AtaiBeckley Inc (ATAI) to Neutral

Jul 16, 2026 10:00AM Oppenheimer on AtaiBeckley Inc (ATAI): 'LLY Acquisition Validates Psychedelic Advantages'

Jul 16, 2026 09:27AM Needham Downgrades AtaiBeckley Inc (ATAI) to Hold

Jul 16, 2026 06:15AM AtaiBeckley (ATAI) call put ratio calls 28.8 calls to 1 put

Jul 15, 2026 07:09PM Lilly Said To Near Deal For Psychedelic Drugmaker Ataibeckley - Bloomberg

Jul 7, 2026 06:59AM AtaiBeckley Inc (ATAI) PT Raised to $17 at Canaccord

Jun 8, 2026 06:56AM H.C. Wainwright Reiterates Buy Rating on AtaiBeckley Inc (ATAI)

May 28, 2026 09:05AM AtaiBeckley launches $60,000 grant program for mental health nonprofits

Apr 20, 2026 03:13PM AtaiBeckley (ATAI) call put ratio 7.3 calls to 1 put with a focus on May calls as share price up 23%

Apr 20, 2026 07:42AM AtaiBeckley Inc (ATAI) PT Raised to $15 at Canaccord

Apr 20, 2026 06:08AM Psychedelic stocks soar after Trump signs executive order to fast-track treatments

Apr 17, 2026 08:14AM AtaiBeckley Inc (ATAI) PT Raised to $16 at Guggenheim

Apr 16, 2026 11:53AM White House Prepares Order On Ibogaine Psychedelic - CBS

Mar 27, 2026 03:25AM Deutsche Bank Starts AtaiBeckley Inc (ATAI) at Buy

Mar 18, 2026 07:58AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Mar 10, 2026 07:23AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Mar 9, 2026 06:04AM AtaiBeckley (ATAI) files mixed shelf

Mar 6, 2026 03:37PM Jefferies Reiterates Buy Rating on atai Life Sciences N.V (ATAI): "keen on ATAI's robust BPL-003 Phase IIb TRD results"

Jan 13, 2026 07:02AM atai Life Sciences (ATAI) Reiterated at Overweight by Cantor Fitzgerald

Jan 8, 2026 07:06AM AtaiBeckley outlines 2026 clinical trial timeline ahead of JP Morgan conference

Dec 23, 2025 07:18AM Jones Trading Starts atai Life Sciences N.V (ATAI) at Buy

Dec 11, 2025 07:00AM AtaiBeckley receives US patent for EMP-01 mental health drug

Nov 14, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Nov 12, 2025 07:59AM atai Life Sciences (ATAI) Misses Q3 EPS by 17c

Nov 10, 2025 07:00AM AtaiBeckley reports positive data on second dose of depression drug

Oct 22, 2025 06:23AM atai Life Sciences N.V (ATAI) PT Raised to $14 at Canaccord Genuity, 'significantly undervalued'

Oct 13, 2025 05:51AM Needham Starts atai Life Sciences N.V (ATAI) at Buy

Sep 24, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Sep 24, 2025 06:29AM Canaccord Genuity Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Sep 15, 2025 07:34AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Aug 14, 2025 07:41AM atai Life Sciences (ATAI) Misses Q2 EPS by 2c

Jul 31, 2025 06:43AM atai Life Sciences N.V (ATAI) PT Raised to $15 at H.C. Wainwright

Jul 29, 2025 06:03AM Oppenheimer Starts atai Life Sciences N.V (ATAI) at Outperform

Jul 2, 2025 11:59AM Aegis Capital Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Jul 2, 2025 06:42AM atai Life Sciences N.V (ATAI) PT Raised to $12 at Canaccord Genuity

Jul 2, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Jul 2, 2025 05:38AM Increasing unusual option volume: ATAI BUR INMB FRSH JKS HUYA

Jul 1, 2025 06:05AM atai Life Sciences (ATAI) Announces $50M Private Placement

Jul 1, 2025 06:01AM atai Life Sciences (ATAI) and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003

Jun 6, 2025 06:10AM Lucid Capital Markets Starts atai Life Sciences N.V (ATAI) at Buy

Jun 3, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

May 20, 2025 07:03AM atai Life Sciences (ATAI) Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

May 14, 2025 04:19PM atai Life Sciences (ATAI) Tops Q1 EPS by 1c

May 13, 2025 07:04AM atai Life Sciences (ATAI) Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

Apr 4, 2025 04:55AM Berenberg Starts atai Life Sciences N.V (ATAI) at Positive

Mar 17, 2025 04:44PM atai Life Sciences (ATAI) Misses Q4 EPS by 9c

Mar 5, 2025 07:08AM atai Life Sciences (ATAI) Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression

Feb 12, 2025 04:02PM atai Life Sciences (ATAI) to offer $55 million in stock

Jan 28, 2025 07:00AM atai Life Sciences (ATAI) Announces Positive Topline Results from Beckley Psytech’s BPL-003

View Older Stories